Detalhe da pesquisa
1.
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.
Int J Mol Sci
; 21(7)2020 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32290082
2.
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
Int J Mol Sci
; 21(12)2020 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32545818
3.
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
Int J Mol Sci
; 21(11)2020 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471207
4.
SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes.
Int J Mol Sci
; 20(15)2019 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31344857
5.
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition.
Lab Invest
; 98(10): 1276-1290, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540859
6.
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.
J Am Soc Nephrol
; 28(2): 575-585, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609616
7.
Structure-activity studies of peptidomimetics based on kinase-inhibitory region of suppressors of cytokine signaling 1.
Biopolymers
; 2017 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154500
8.
Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Diabetologia
; 58(7): 1656-67, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25982245
9.
Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.
Basic Res Cardiol
; 110(2): 8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25604439
10.
Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Arterioscler Thromb Vasc Biol
; 34(9): 1953-60, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012131
11.
Role of chemokines in proteinuric kidney disorders.
Expert Rev Mol Med
; 16: e3, 2014 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24534600
12.
Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Am J Pathol
; 182(5): 1910-21, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23597852
13.
Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.
Brain
; 135(Pt 9): 2826-37, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22961553
14.
Fcγ receptor deficiency attenuates diabetic nephropathy.
J Am Soc Nephrol
; 23(9): 1518-27, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22859852
15.
Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?
BMC Nephrol
; 13: 21, 2012 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22533828
16.
Animal models of cardiovascular diseases.
J Biomed Biotechnol
; 2011: 497841, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21403831
17.
Suppressors of cytokine signaling abrogate diabetic nephropathy.
J Am Soc Nephrol
; 21(5): 763-72, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20185635
18.
Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Arterioscler Thromb Vasc Biol
; 29(4): 525-31, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19164812
19.
Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated Evidence.
Antioxidants (Basel)
; 9(12)2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287432
20.
The Coming Age of Flavonoids in the Treatment of Diabetic Complications.
J Clin Med
; 9(2)2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012726